N-(3-4-[3-(trifluoromethyl)phenyl]piperazin-1-ylpropyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand | Publicación